FMR1 and multiple system atrophy: Due to the overlap in symptoms, the European MSA study group screened for FMR1 repeat expansions in a large cohort of clinically diagnosed MSA individuals and found them in ≤ 1% of cases (n = 4/426), but in 4% of those presenting with a MSA-C phenotype (n = 3/76) [80].